Amyris, Inc. Sells Brazilian Production Facility to Royal DSM

Heerlen, The Netherlands, and Emeryville, CA - Dec. 29, 2017 - Royal DSM (AEX:DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, announced on Dec. 29, 2017 that they have closed the transaction for the sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris's high-volume products. 

The announcement of the intended transaction was made on November 17, 2017, and the details can be found here.

For more information, please contact Peter DeNardo at 510-740-7481.